Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiwei Fanghai Granules as Adjuvant to Radiotherapy in Nasopharyngeal Carcinoma
CTR20150556Phase 2Active
- Sponsor
- Guangdong Yikang Pharmaceutical
- Start
- Aug 2015
- Countries
- 1
01
Overview
A Phase 2 trial of Qiwei Fanghai granules in nasopharyngeal carcinoma (NPC), sponsored by Guangdong Yikang Pharmaceutical. Started Aug 2015; status: active.
02
Drugs
Qiwei Fanghai granules
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on CTR20150556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150556.